Incannex Healthcare (IXHL) Long-Term Deferred Tax (2020 - 2023)
Incannex Healthcare's (IXHL) quarterly Long-Term Deferred Tax came in at $4.0 million in Q2 2023, up 18.82% year-over-year from $3.4 million in Q2 2022, and up 18.82% quarter-over-quarter from $3.4 million in Q2 2022.
Analysis
Incannex Healthcare (IXHL) Long-Term Deferred Tax (2020 - 2023) Analysis & Trends
Incannex Healthcare has disclosed Long-Term Deferred Tax across 4 years of filings, most recently posting $4.0 million for Q2 2023.
- In Q2 2023, Long-Term Deferred Tax rose 18.82% year-over-year to $4.0 million; the TTM figure through Jun 2023 stood at $4.0 million (up 18.82% YoY), while the FY2023 annual figure was $4.0 million, up 18.82% from the prior year.
- Long-Term Deferred Tax came in at $4.0 million for Q2 2023 at Incannex Healthcare, up from $3.4 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $4.0 million in Q2 2023 to a low of $1.1 million in Q2 2020.
- Average Long-Term Deferred Tax over 4 years is $2.6 million, with a median of $2.6 million recorded in 2021.
- Year-over-year, Long-Term Deferred Tax jumped 90.2% in 2022 and rose 18.82% in 2023.
- Over 4 years, Long-Term Deferred Tax stood at $1.1 million in 2020, then surged by 55.31% to $1.8 million in 2021, then jumped by 90.2% to $3.4 million in 2022, then advanced by 18.82% to $4.0 million in 2023.
- Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $4.0 million in Q2 2023, $3.4 million in Q2 2022, and $1.8 million in Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn |
| 2 | AbbVie | 442.18 Bn | 435.61 Bn | 12.70 Bn |
| 3 | Merck | 366.59 Bn | 359.45 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.49 Bn | 258.80 Bn | 11.24 Bn |
| 5 | Pfizer | 159.09 Bn | 147.39 Bn | 10.94 Bn |
| 6 | Sanofi | 52.34 Bn | 44.96 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.53 Bn | 18.87 Bn | 683.80 Mn |
| 10 | Incannex Healthcare | 40.87 Mn | 40.87 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 3.99 Mn |
| Jun 30, 2022 | 3.36 Mn |
| Jun 30, 2021 | 1.76 Mn |
| Jun 30, 2020 | 1.14 Mn |